Intus Bio

Curated by Signal

Developer of sequencing technology for microbiome testing, pathogen identification, and tracking

Overview

Developer of sequencing technology for microbiome testing, pathogen identification, and tracking. It offers a platform, called Titan-1 which ses a patented 16S-ITS-23S amplicon to generate information to differentiate strains without sequencing the whole genome.

Key facts

Founded: 2014
Headquarters: Farmington, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Myomo
Provider of a robotic arm for mobility and rehabilitation
Life Sciences TechnologyBoston, United States
Arpeggio
Provider of drug discovery platform for the treatment of cancer
Life Sciences TechnologyBoulder, United States
FORE-SIGHT
Cerebral oximetry device
Life Sciences TechnologyBranford, United States

About Intus Bio

What does Intus Bio do?

Developer of sequencing technology for microbiome testing, pathogen identification, and tracking.

Where is Intus Bio headquartered?

Intus Bio is headquartered in Farmington, United States.

When was Intus Bio founded?

Intus Bio was founded in 2014.

Which sector is Intus Bio in?

Intus Bio operates in Life Sciences Technology.

Who are Intus Bio's competitors?

Companies similar to Intus Bio include Myomo, Arpeggio, and FORE-SIGHT.